Get monthly updates on metabolomics news and events
All posts to the category
Read in this article about how exposomics and metabolomics together provide a powerful, complementary framework for advancing 5P medicine by linking environmental exposures with measurable metabolic phenotypes.
Eicosapentaenoic acid (EPA) is an omega‑3 polyunsaturated fatty acid that acts as a precursor to specialized pro‑resolving mediators, including resolvins, which actively dampen inflammatory responses.
Metabolomics as an accelerator of 5P medicine |
Part 1: Polyamine acetylation as a driver of immunotherapy response
This year’s Arizona Metabolomics & T32 Symposium was hosted by Dr. Haiwei Gu and Dr. Corrie Whisner at Arizona State University in Phoenix, AZ. This one-day event highlighted a variety of emerging research topics and applications in the field of metabolomics, systems biology, and health.
Dimethylglycine is a molecular entry point into individualized, systems-oriented healthcare. Altered DMG levels have been linked to cardiometabolic risk and conditions such as myocardial infarction, diabetes, and metabolic dysfunction-associated liver disease.